comparemela.com

Latest Breaking News On - Randalw scott - Page 5 : comparemela.com

313,381 Shares in BridgeBio Pharma, Inc. (NASDAQ:BBIO) Purchased by Boone Capital Management LLC

313,381 Shares in BridgeBio Pharma, Inc. (NASDAQ:BBIO) Purchased by Boone Capital Management LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
Hannah-valantine
Bio-pharma
Bridgebio-pharma
Randalw-scott
Nasdaq
Bio-pharma-inc
Exchange-commission
China-universal-asset-management-co
Covestor-ltd
Bridgebio-pharma-inc
Securities-exchange-commission

Boone Capital Management LLC Makes New $8.26 Million Investment in BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Boone Capital Management LLC Makes New $8.26 Million Investment in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Bridgebio-pharma
Randalw-scott
Bio-pharma
Hannah-valantine
Cantor-fitzgerald
Topco-ltd
Bridgebio-pharma-company-profile
Bridgebio-pharma-inc
Securities-exchange-commission
Wells-fargo-company
Boone-capital-management
Citigroup

BridgeBio Pharma (NASDAQ:BBIO) Issues Earnings Results

BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) issued its earnings results on Thursday. The company reported ($0.96) EPS for the quarter, missing analysts’ consensus estimates of ($0.87) by ($0.09), Briefing.com reports. The company had revenue of $1.74 million for the quarter, compared to the consensus estimate of $4.78 million. The firm’s revenue for the quarter […]

Frank-mccormick
Randalw-scott
Bridgebio-pharma
Bio-pharma
Cantor-fitzgerald
Topco-ltd
Bridgebio-pharma-company-profile
Wells-fargo-company
Ameritas-investment-partners-inc
Citigroup
Securities-exchange-commission
Bridgebio-pharma-inc

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Acquired by Covestor Ltd

Covestor Ltd raised its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 131.5% in the third quarter, Holdings Channel.com reports. The fund owned 9,587 shares of the company’s stock after acquiring an additional 5,446 shares during the period. Covestor Ltd’s holdings in BridgeBio Pharma were worth $252,000 at the end of the most […]

Bio-pharma
Randalw-scott
Hannah-valantine
Bridgebio-pharma-inc
Bridgebio-pharma-company-profile
Cantor-fitzgerald
Covestor-ltd-bio-pharma
Envestnet-asset-management-inc
Securities-exchange-commission
Wells-fargo-company
Covestor-ltd
Holdings-channel

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Rating of "Moderate Buy" by Brokerages

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twelve analysts that are currently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average twelve-month target […]

Bridgebio-pharma
Randalw-scott
Frank-mccormick
Bio-pharma
Cantor-fitzgerald
Securities-exchange-commission
Moody-aldrich-partners
Emerald-mutual-fund-advisers
Wells-fargo-company
Emerald-advisers
Bridgebio-pharma-inc
Campbell-co-investment-adviser

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.